Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives01:35

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives

2.6K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.6K
Nucleic Acids02:43

Nucleic Acids

49.9K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
49.9K
Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Titration of a Polyprotic Acid02:08

Titration of a Polyprotic Acid

104.1K
A polyprotic acid contains more than one ionizable hydrogen and undergoes a stepwise ionization process.  If the acid dissociation constants of the ionizable protons differ sufficiently from each other, then the titration curve for such polyprotic acid generates a distinct equivalence point for each of its ionizable hydrogens. Therefore, titration of a diprotic acid results in the formation of two equivalence points, whereas the titration of a triprotic acid results in the formation of three...
104.1K
Amino acids03:42

Amino acids

104.7K
Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
104.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Supportive Care Needs Among Pretreatment Head and Neck Cancer Patients According to Smoking Status: A Cross-Sectional Study With Nested Analyses.

Laryngoscope investigative otolaryngology·2026
Same author

Stimuli-responsive STING nanovaccine for systemic therapy of HPV-induced cancers.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Protocol for integrating immunohistochemistry and H&E annotations with Xenium data at single-cell resolution.

STAR protocols·2025
Same author

A Multi-Threshold Micelle Improves Tumor Accumulation and STING Immunotherapy.

Journal of the American Chemical Society·2025
Same author

HYHOPE: A Phase 1 Study of Deintensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer.

International journal of radiation oncology, biology, physics·2025

関連する実験動画

Updated: Jan 23, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.6K

腫瘍活性化インターロイキン-2療法の重度酸性度標的化

Qiang Feng1, Raymundo Pantoja2, Jacqueline G Lopez3

  • 1Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, USA; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Cell reports. Medicine
|January 21, 2026
PubMed
まとめ

新規ナノ粒子システムは、超pH感受性ポリマーを利用して腫瘍内で特異的にインターロイキン-2(IL-2)を活性化します。このアプローチは、全身毒性を低減し、がん免疫療法の有効性を高めます。

キーワード:
がん免疫療法サイトカイン療法免疫工学免疫関連毒性インターロイキン-2pH感受性ナノ粒子

さらに関連する動画

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

関連する実験動画

Last Updated: Jan 23, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

科学分野:

  • バイオテクノロジー
  • 免疫療法
  • 材料科学

背景:

  • インターロイキン-2(IL-2)はがん免疫療法において有望ですが、治療域が狭く、臨床応用が制限されています。
  • 既存のIL-2-Fc融合タンパク質や共有結合型プロドラッグなどの戦略は、全身毒性、効力低下、適用性の問題に直面しています。
  • IL-2の腫瘍特異的活性化は、治療指数を改善するために不可欠です。

主な方法:

  • 臨床的に検証された超pH感受性(UPS)ポリマーとIL-2-Fcを用いたナノ粒子の製剤化。
  • 生理的および腫瘍特異的酸性pHでのナノ粒子の安定性と解離の評価。
  • 前臨床モデルにおける全身毒性マーカー(例:インターフェロンγ、血管漏出症候群)および抗腫瘍効果の評価。

結論:

  • 非共有結合型のpH感受性ナノ粒子システムは、腫瘍特異的なIL-2活性化を可能にし、従来の治療法の限界を克服します。
  • この生物工学的戦略は、IL-2免疫療法に関連する全身毒性を大幅に低減します。
  • UPS/IL-2-Fcナノ粒子は、より広い治療域を持つがん免疫療法の強化のための有望なプラットフォームを表します。